Maintenance therapy for locally advanced or metastatic urothelial carcinoma

被引：0
|
作者：
Rexer, H. [1 ]
Banek, S. [2 ]
Merseburger, A. [3 ]
机构：
[1] AUO Geschaftsstelle, Schwarz, Germany
[2] Univ Klinikum Frankfurt, Klin Urol & Kinderurol, LPIG, Frankfurt, Germany
[3] Deutsch Krebsgesell eV, Arbeitsgemeinschaft Urol Onkol, Berlin, Germany
来源：
UROLOGIE | 2024年 / 63卷 / 02期
关键词：
D O I：
10.1007/s00120-024-02284-9
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：208 / 209
页数：2
相关论文
共 50 条
  • [41] Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma.
    Dinan, Michaela Ann
    Georgieva, Mihaela
    Shenolikar, Rahul
    Scales, Charles D.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [42] Atezolizumab (atezo) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC): outcomes by prior therapy
    von Amsberg, G.
    Perez-Garcia, J. L.
    Loriot, Y.
    Rosenberg, J. E.
    Powles, T.
    Necchi, A.
    Hussain, S. A.
    Morales-Barrera, R.
    Retz, M.
    Niegisch, G.
    Duran, I.
    Theodore, C.
    Grande, E.
    Thastrom, A. C.
    Li, S.
    Abidoye, O. O.
    Van Der Heijden, M. S.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 115 - 115
  • [43] First-line-Therapy for locally advanced or metastasized Urothelial carcinoma
    Rexer, H.
    UROLOGE, 2011, 50 (12): : 1617 - 1618
  • [44] Avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma: Applying clinical trial findings to clinical practice
    Grivas, Petros
    Agarwal, Neeraj
    Pal, Sumanta
    Kalebasty, Arash Rezazadeh
    Sridhar, Srikala S.
    Smith, Jodi
    Devgan, Geeta
    Sternberg, Cora N.
    Bellmunt, Joaquim
    CANCER TREATMENT REVIEWS, 2021, 97
  • [45] Real-World Treatment Patterns and Clinical Outcomes in Patients With Locally Advanced or Metastatic Urothelial Carcinoma by Eligibility for Maintenance Avelumab
    Morgans, Alicia K.
    Sonpavde, Guru P.
    Shih, Vanessa
    Wright, Phoebe
    Hepp, Zsolt
    Willmon, Candice L.
    Chang, Nancy N.
    Mucha, Lisa
    Naga, Sai Sriteja Boppudi
    Powles, Thomas
    CLINICAL GENITOURINARY CANCER, 2024, 23 (01)
  • [46] Immunotherapy maintenance therapy for advanced urothelial carcinoma (aUC): a comprehensive review
    Carril-Ajuria, Lucia
    Cruz Martin-Soberon, Maria
    de Velasco, Guillermo
    Agarwal, Neeraj
    Castellano, Daniel
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (05) : 1097 - 1105
  • [47] Immunotherapy maintenance therapy for advanced urothelial carcinoma (aUC): a comprehensive review
    Lucia Carril-Ajuria
    Maria Cruz Martin-Soberón
    Guillermo de Velasco
    Neeraj Agarwal
    Daniel Castellano
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 1097 - 1105
  • [48] Latin American Consensus for the Evaluation and Treatment of Patients With Metastatic/Locally Advanced Urothelial Carcinoma
    Kopp, Ray Manneh
    Galanternik, Fernando
    Schutz, Fabio A.
    Kater, Fabio
    Ramos-Esquivel, Allan
    Neciosup, Silvia
    Sobrevilla-Moreno, Nora
    Vaca, Laura Bernal
    Ibata-Bernal, Linda
    Martinez-Rojas, Susan
    Bourlon, Maria T.
    JCO GLOBAL ONCOLOGY, 2024, 10
  • [49] Exposure-response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma
    Dosne, Anne-Gaelle
    Valade, Elodie
    Goeyvaerts, Nele
    De Porre, Peter
    Avadhani, Anjali
    O'Hagan, Anne
    Li, Lilian Y.
    Ouellet, Daniele
    Ruixo, Juan Jose Perez
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 89 (02) : 151 - 164
  • [50] SYSTEMATIC LITERATURE REVIEW OF TREATMENT PATTERNS OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
    Hepp, Z.
    Shah, S. N.
    Vadagam, P.
    Smoyer, K.
    VALUE IN HEALTH, 2019, 22 : S94 - S94
12345